These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. The aminoglycoside antibiotics. Langslet J; Habel ML Am J Nurs; 1981 Jun; 81(6):1144-6. PubMed ID: 6909002 [No Abstract] [Full Text] [Related]
27. Antibiotic selection and pharmacokinetics in the critically ill. Bush LM; Levison ME Crit Care Clin; 1988 Apr; 4(2):299-324. PubMed ID: 3048589 [TBL] [Abstract][Full Text] [Related]
29. What is the relevance of fosfomycin pharmacokinetics in the treatment of serious infections in critically ill patients? A systematic review. Parker S; Lipman J; Koulenti D; Dimopoulos G; Roberts JA Int J Antimicrob Agents; 2013 Oct; 42(4):289-93. PubMed ID: 23880170 [TBL] [Abstract][Full Text] [Related]
30. [Level of evidence for therapeutic drug monitoring of aminoglycosides]. Venisse N; Boulamery A; Therapie; 2011; 66(1):39-44. PubMed ID: 21466776 [TBL] [Abstract][Full Text] [Related]
31. Aminoglycosides in intermittent hemodialysis: pharmacokinetics with individual dosing. Dager WE; King JH Ann Pharmacother; 2006 Jan; 40(1):9-14. PubMed ID: 16332944 [TBL] [Abstract][Full Text] [Related]
32. Aminoglycosides in gynecologic infections. Ledger WJ Am J Med; 1986 Jun; 80(6B):216-21. PubMed ID: 3728531 [TBL] [Abstract][Full Text] [Related]
33. Rational use of aminoglycosides--review and recommendations by the Swedish Reference Group for Antibiotics (SRGA). Hanberger H; Edlund C; Furebring M; G Giske C; Melhus A; Nilsson LE; Petersson J; Sjölin J; Ternhag A; Werner M; Eliasson E; Scand J Infect Dis; 2013 Mar; 45(3):161-75. PubMed ID: 23270477 [TBL] [Abstract][Full Text] [Related]
34. [Which partner for the betalactam agent in empirical combined therapy? II. Aminoglycoside]. Mimoz O; Grollier G Ann Fr Anesth Reanim; 2004 Jun; 23(6):639-42. PubMed ID: 15234735 [No Abstract] [Full Text] [Related]
35. Use of antibacterial agents in renal failure. Gilbert B; Robbins P; Livornese LL Infect Dis Clin North Am; 2009 Dec; 23(4):899-924, viii. PubMed ID: 19909890 [TBL] [Abstract][Full Text] [Related]
36. [Febrile neutropenia: empiric antibiotic therapy from 1975 to 1997]. Klastersky J Rev Med Brux; 1997 Oct; 18(5):323-7. PubMed ID: 9441328 [TBL] [Abstract][Full Text] [Related]
37. Aminoglycoside drugs in clinical practice: an evidence-based approach. Leibovici L; Vidal L; Paul M J Antimicrob Chemother; 2009 Feb; 63(2):246-51. PubMed ID: 19022778 [TBL] [Abstract][Full Text] [Related]
38. Aminoglycoside antibiotics in the treatment of otologic infections. Matz GJ; Lerner SA; Lanzl EF Otolaryngol Head Neck Surg; 1981; 89(5):705-9. PubMed ID: 6799892 [TBL] [Abstract][Full Text] [Related]
39. [Changes in the dosing of colistimethate sodium in critically ill patients]. Ortega-García MP; Abril-López de Medrano V; Gimeno-Cardona C Rev Esp Quimioter; 2016 Feb; 29(1):53-4. PubMed ID: 26785228 [No Abstract] [Full Text] [Related]
40. Changes in microbial ecology by therapeutic use of aminoglycosides. Bauernfeind A; Hörl G; Mönch V Scand J Infect Dis Suppl; 1986; 49():106-14. PubMed ID: 3547617 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]